Clinical Trial Update: Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports safety and efficacy of luliconazole 10% solution for mild-to-moderate onychomycosis in Phase 2/3, with the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• Luliconazole 10% Solution (luliconazole)

Snippet

Sponsor: Topica Pharmaceuticals | Conditions: Distal and Lateral Subungual Onychomycosis | Phase 2, Phase 3 | Status: COMPLETED